Shulamith H. Shafer

Array ( [id] => 11100909 [patent_doc_number] => 20160297879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'Uses and Compositions for Treatment of Psoriatic Arthritis' [patent_app_type] => utility [patent_app_number] => 14/944891 [patent_app_country] => US [patent_app_date] => 2015-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41230 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14944891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11083812 [patent_doc_number] => 20160280776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'Uses and Compositions for Treatment of Juvenile Rheumatoid Arthritis' [patent_app_type] => utility [patent_app_number] => 14/935991 [patent_app_country] => US [patent_app_date] => 2015-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28608 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14935991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11895212 [patent_doc_number] => 09765137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Early marker of proteinuria in patients treated with an anti-VEGF treatment' [patent_app_type] => utility [patent_app_number] => 14/935784 [patent_app_country] => US [patent_app_date] => 2015-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5424 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14935784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11560525 [patent_doc_number] => 09623085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Chimeric natriuretic peptide compositions and methods of preparation' [patent_app_type] => utility [patent_app_number] => 14/934617 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 15164 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14934617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11094043 [patent_doc_number] => 20160291011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'Biomarkers for Cardiodiabetes' [patent_app_type] => utility [patent_app_number] => 14/932623 [patent_app_country] => US [patent_app_date] => 2015-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17309 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14932623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10700572 [patent_doc_number] => 20160046720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'NOVEL ANTI-HUMAN TSLP RECEPTOR ANTIBODY' [patent_app_type] => utility [patent_app_number] => 14/927007 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13717 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14927007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12030830 [patent_doc_number] => 20170320929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'Fragments Of Syndecan-2 Having Anti-Angiogenic Activity' [patent_app_type] => utility [patent_app_number] => 15/520149 [patent_app_country] => US [patent_app_date] => 2015-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8167 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10685853 [patent_doc_number] => 20160031998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'ANTIBODIES AGAINST G-CSFR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/886176 [patent_app_country] => US [patent_app_date] => 2015-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30367 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14886176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11943523 [patent_doc_number] => 20170247674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'CONJUGATES FOR DELIVERY TO MITOCHONDRIA' [patent_app_type] => utility [patent_app_number] => 15/519369 [patent_app_country] => US [patent_app_date] => 2015-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26828 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684417 [patent_doc_number] => 20160030563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'CONCENTRATED HUMAN IMMUNOGLOBULIN COMPOSITION' [patent_app_type] => utility [patent_app_number] => 14/879673 [patent_app_country] => US [patent_app_date] => 2015-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7312 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14879673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10676547 [patent_doc_number] => 20160022692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'TREATMENT OF RHEUMATOID ARTHRITIS AND ASTHMA USING PI3 KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/876589 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 65825 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 52 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14171719 [patent_doc_number] => 10259855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => Methods and compositions for treating cancer [patent_app_type] => utility [patent_app_number] => 15/515442 [patent_app_country] => US [patent_app_date] => 2015-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 19969 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799161 [patent_doc_number] => 20160145318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM BLOOD' [patent_app_type] => utility [patent_app_number] => 14/859705 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17771 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14859705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12087009 [patent_doc_number] => 09840728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-12 [patent_title] => 'SRM assay to indicate cancer therapy' [patent_app_type] => utility [patent_app_number] => 14/855154 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12417 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11894082 [patent_doc_number] => 09764002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Dosage regimen for therapeutic method' [patent_app_type] => utility [patent_app_number] => 14/853799 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 10815 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11003868 [patent_doc_number] => 20160200817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'Methods Of Identifying Anti-Inflammatory Compounds' [patent_app_type] => utility [patent_app_number] => 14/851949 [patent_app_country] => US [patent_app_date] => 2015-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17364 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10738701 [patent_doc_number] => 20160084852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'METHODS OF DETERMINATION OF ACTIVATION OR INACTIVATION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AND BRAIN NATRIURETIC PEPTIDE (BNP) HORMONAL SYSTEMS' [patent_app_type] => utility [patent_app_number] => 14/841863 [patent_app_country] => US [patent_app_date] => 2015-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16116 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14841863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11935184 [patent_doc_number] => 20170239333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'METHODS FOR PREVENTING PREMATURE FOLLICLE ACTIVATION' [patent_app_type] => utility [patent_app_number] => 15/506496 [patent_app_country] => US [patent_app_date] => 2015-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6789 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11003860 [patent_doc_number] => 20160200809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'Uses and Compositions for Treatment of Psoriasis' [patent_app_type] => utility [patent_app_number] => 14/828084 [patent_app_country] => US [patent_app_date] => 2015-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 58883 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14828084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11936482 [patent_doc_number] => 20170240631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/502766 [patent_app_country] => US [patent_app_date] => 2015-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 127380 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502766 [rel_patent_id] =>[rel_patent_doc_number] =>)